WESTLAKE, Ohio, Aug. 4 /PRNewswire/ -- Radiometer today announced it has received 510(k) clearance from the U.S. Food and Drug Administration for its ABL80 FLEX CO-OX, a portable blood gas analyzer that brings speed and simplicity to the point-of-care. The company expects commercial release of the instrument to soon follow.
Benchtop performance in a small package
The ABL80 FLEX CO-OX accurately measures pH, blood gases, electrolytes, glucose and vital CO-oximetry parameters. CO-oximetry provides critical information to the clinician for assessment of the acutely ill patient's oxygen status, including oxygen uptake, transport and release.
The ABL80 FLEX CO-OX matches the CO-oximetry performance of Radiometer's benchtop analyzers, representing Radiometer's commitment to providing quality solutions for both laboratory and point-of-care testing.
Radiometer's sophisticated CO-oximetry technology utilizes
multi-wavelength technology for high measurement performance combined with
an ultrasonic hemolyzation process. Ultrasonic hemolyzation offers
advantages over chemical hemolyzation, including low maintenance and zero
risk of interference from chemical hemolyzing agents or partially hemolyzed
red blood cells.
In addition to lab-quality CO-oximetry, the ABL80 FLEX CO-OX provides:
-- Fast turnaround, with only 140 seconds between results
-- Easy, cartridge-based testing+
-- Small sample size of 105 microliters
-- Fast start-up after installation of new consumables
-- Portability, with full operation on battery power
-- Minimal maintenance, with a self-cleaning sample inlet
-- Automatic QC, with automated corrective actions
-- Full connectivity to the HIS/LIS
Radiometer is a world leader in the development, manufacture and
distribution of technologically advanced acute care testing solutions.
Radiometer's products and ser
Copyright©2008 PR Newswire.
All rights reserved